Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Untranslated | 2 | 2020 | 19 | 1.260 |
Why?
|
| Sequence Analysis, RNA | 3 | 2025 | 157 | 0.710 |
Why?
|
| Databases, Nucleic Acid | 1 | 2020 | 8 | 0.680 |
Why?
|
| Liver Cirrhosis | 4 | 2025 | 160 | 0.650 |
Why?
|
| Statistics as Topic | 1 | 2018 | 146 | 0.570 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 713 | 0.440 |
Why?
|
| Hepatic Stellate Cells | 2 | 2024 | 20 | 0.420 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 106 | 0.350 |
Why?
|
| Ondansetron | 2 | 2024 | 34 | 0.340 |
Why?
|
| Simvastatin | 2 | 2024 | 28 | 0.340 |
Why?
|
| Federal Government | 1 | 2009 | 20 | 0.330 |
Why?
|
| Education | 1 | 2009 | 74 | 0.320 |
Why?
|
| Schizophrenia | 2 | 2024 | 250 | 0.290 |
Why?
|
| Antipsychotic Agents | 2 | 2024 | 311 | 0.270 |
Why?
|
| Memory, Long-Term | 2 | 2016 | 7 | 0.270 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 262 | 0.240 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2024 | 7 | 0.240 |
Why?
|
| Drug Therapy, Combination | 2 | 2024 | 436 | 0.230 |
Why?
|
| Pakistan | 5 | 2024 | 14 | 0.230 |
Why?
|
| Gene Expression | 3 | 2019 | 808 | 0.230 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2025 | 152 | 0.230 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2024 | 15 | 0.230 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 95 | 0.230 |
Why?
|
| Transcriptome | 2 | 2025 | 337 | 0.220 |
Why?
|
| Chromatin | 3 | 2022 | 602 | 0.220 |
Why?
|
| Hepatocytes | 1 | 2025 | 195 | 0.210 |
Why?
|
| Mice | 10 | 2024 | 10317 | 0.210 |
Why?
|
| Software | 2 | 2018 | 376 | 0.210 |
Why?
|
| Fatty Liver | 1 | 2023 | 96 | 0.200 |
Why?
|
| Enterovirus | 1 | 2022 | 1 | 0.200 |
Why?
|
| MicroRNAs | 3 | 2019 | 617 | 0.200 |
Why?
|
| Abortion, Veterinary | 1 | 2022 | 1 | 0.200 |
Why?
|
| Camelus | 1 | 2022 | 1 | 0.200 |
Why?
|
| Cognition | 2 | 2024 | 466 | 0.200 |
Why?
|
| Cicatrix | 1 | 2022 | 58 | 0.190 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 151 | 0.190 |
Why?
|
| Animals | 13 | 2024 | 19739 | 0.190 |
Why?
|
| Viruses | 1 | 2022 | 79 | 0.180 |
Why?
|
| Crohn Disease | 1 | 2022 | 113 | 0.180 |
Why?
|
| Microbiota | 1 | 2022 | 104 | 0.180 |
Why?
|
| Liver | 1 | 2025 | 785 | 0.170 |
Why?
|
| DNA Methylation | 3 | 2018 | 275 | 0.170 |
Why?
|
| Brain | 2 | 2018 | 1485 | 0.170 |
Why?
|
| RNA, Bacterial | 1 | 2020 | 69 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2020 | 179 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 63 | 0.160 |
Why?
|
| Cattle | 1 | 2020 | 305 | 0.160 |
Why?
|
| Rats | 2 | 2020 | 1908 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2018 | 15 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 28 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2020 | 112 | 0.160 |
Why?
|
| Base Sequence | 2 | 2018 | 1301 | 0.150 |
Why?
|
| Nucleic Acids | 1 | 2019 | 50 | 0.150 |
Why?
|
| Codon | 1 | 2018 | 49 | 0.150 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 202 | 0.150 |
Why?
|
| Organogenesis | 1 | 2018 | 40 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2020 | 113 | 0.150 |
Why?
|
| RNA, Viral | 1 | 2020 | 265 | 0.150 |
Why?
|
| Internet | 2 | 2020 | 465 | 0.150 |
Why?
|
| beta-Galactosidase | 1 | 2018 | 81 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2020 | 137 | 0.150 |
Why?
|
| Homovanillic Acid | 1 | 2017 | 6 | 0.140 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2017 | 11 | 0.140 |
Why?
|
| Monoamine Oxidase | 1 | 2017 | 8 | 0.140 |
Why?
|
| Paroxetine | 1 | 2017 | 15 | 0.140 |
Why?
|
| Fluoxetine | 1 | 2017 | 44 | 0.140 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2017 | 28 | 0.140 |
Why?
|
| Hippocampus | 1 | 2018 | 241 | 0.140 |
Why?
|
| Computational Biology | 2 | 2018 | 337 | 0.140 |
Why?
|
| Stem Cells | 1 | 2018 | 258 | 0.130 |
Why?
|
| RNA Splicing | 1 | 2017 | 160 | 0.130 |
Why?
|
| Kidney | 1 | 2018 | 397 | 0.130 |
Why?
|
| Affect | 1 | 2017 | 125 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 416 | 0.130 |
Why?
|
| Epigenesis, Genetic | 2 | 2016 | 353 | 0.130 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2015 | 9 | 0.130 |
Why?
|
| Oryzias | 1 | 2015 | 5 | 0.130 |
Why?
|
| Histones | 2 | 2016 | 465 | 0.130 |
Why?
|
| Gyrus Cinguli | 1 | 2015 | 57 | 0.120 |
Why?
|
| Memory, Short-Term | 1 | 2015 | 59 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2015 | 85 | 0.120 |
Why?
|
| Online Systems | 1 | 2015 | 21 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 140 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2015 | 216 | 0.110 |
Why?
|
| Self-Injurious Behavior | 1 | 2014 | 47 | 0.110 |
Why?
|
| Humans | 13 | 2025 | 60081 | 0.110 |
Why?
|
| Serotonin Antagonists | 1 | 2013 | 30 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 161 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 215 | 0.090 |
Why?
|
| Depression | 1 | 2017 | 868 | 0.090 |
Why?
|
| Male | 8 | 2025 | 27951 | 0.080 |
Why?
|
| Schizophrenic Psychology | 2 | 2024 | 65 | 0.080 |
Why?
|
| Education, Graduate | 1 | 2009 | 14 | 0.080 |
Why?
|
| Emigration and Immigration | 1 | 2009 | 25 | 0.080 |
Why?
|
| RNA, Messenger | 3 | 2019 | 1465 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2024 | 684 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2024 | 5266 | 0.070 |
Why?
|
| Young Adult | 3 | 2024 | 4398 | 0.060 |
Why?
|
| Adolescent | 3 | 2024 | 5944 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2024 | 38 | 0.060 |
Why?
|
| Adult | 4 | 2025 | 15972 | 0.060 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2023 | 53 | 0.050 |
Why?
|
| Antigens, Nuclear | 1 | 2022 | 19 | 0.050 |
Why?
|
| Female | 5 | 2025 | 31226 | 0.050 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2022 | 13 | 0.050 |
Why?
|
| Ethers | 1 | 2022 | 17 | 0.050 |
Why?
|
| Spiro Compounds | 1 | 2022 | 11 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2022 | 44 | 0.050 |
Why?
|
| Superovulation | 1 | 2022 | 2 | 0.050 |
Why?
|
| Immunomodulation | 1 | 2022 | 27 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 31 | 0.050 |
Why?
|
| Embryo Transfer | 1 | 2022 | 23 | 0.050 |
Why?
|
| Fibrosis | 1 | 2022 | 151 | 0.050 |
Why?
|
| Collagen | 1 | 2022 | 118 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3215 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 34 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1053 | 0.040 |
Why?
|
| Nephrons | 1 | 2018 | 7 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 1015 | 0.040 |
Why?
|
| Base Composition | 1 | 2018 | 27 | 0.040 |
Why?
|
| Proteostasis | 1 | 2018 | 11 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 175 | 0.040 |
Why?
|
| Nucleotides | 1 | 2018 | 41 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2019 | 379 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2018 | 179 | 0.040 |
Why?
|
| Phenotype | 1 | 2022 | 1145 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 16542 | 0.040 |
Why?
|
| Disease | 1 | 2017 | 26 | 0.040 |
Why?
|
| Amino Acids | 1 | 2018 | 139 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2017 | 5 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 264 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2017 | 104 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 288 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 252 | 0.030 |
Why?
|
| Exons | 1 | 2017 | 190 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2018 | 258 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2074 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 852 | 0.030 |
Why?
|
| Genomics | 1 | 2019 | 317 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 735 | 0.030 |
Why?
|
| Mammals | 1 | 2017 | 207 | 0.030 |
Why?
|
| Suicidal Ideation | 1 | 2017 | 114 | 0.030 |
Why?
|
| Protein Folding | 1 | 2017 | 261 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 221 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 1100 | 0.030 |
Why?
|
| Aged | 2 | 2024 | 13596 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 296 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1111 | 0.030 |
Why?
|
| Fear | 1 | 2015 | 67 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 59 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1572 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 630 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 326 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 1482 | 0.030 |
Why?
|
| Pregnancy | 1 | 2022 | 2361 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1064 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2095 | 0.030 |
Why?
|
| Problem Solving | 1 | 2014 | 30 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 1995 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1298 | 0.030 |
Why?
|
| Brazil | 1 | 2013 | 89 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 281 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1542 | 0.030 |
Why?
|
| Checklist | 1 | 2013 | 75 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1471 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1214 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2013 | 137 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 264 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 386 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 353 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 6147 | 0.020 |
Why?
|
| Research Design | 1 | 2013 | 569 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 2466 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 2360 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 3621 | 0.020 |
Why?
|